Commentary by Dr. Donald Greig As we finally conclude our Movember series, albeit extending slightly into December on prostate health, we find ourselves at a pivotal moment in the conversation about PSA screening. In previous newsletters, we explored the complexities and potential downsides of mass population screening, including concerns about overdiagnosis and the associated risks of treatment. However, new findings from a groundbreaking European trial involving 162,000 men have...

Commentary by Dr. Donald Greig Movember: prostate cancer awareness month! As Movember draws to a close, we've journeyed through the complexities of prostate cancer screening—from the PSA test's double-edged sword and groundbreaking PSMA-PET imaging to the life-saving urgency of showing up for check-ups. But prostate health isn't just about cancer; it's a broader story of men's wellness that often flies under the radar. In this penultimate instalment of our series , Beyond the Walnut:...

Commentary by Dr. Donald Greig In our ongoing Movember spotlight on men's health—picking up from breakthroughs like PSMA-PET imaging and the screening debates—today's focus is a stark reminder: Early detection isn't optional; it's lifesaving. A massive 20-year study from the European Randomized Study of Screening for Prostate Cancer (ERSPC), presented at the European Association of Urology (EAU) Congress, tracked 161,000 men across seven countries. The verdict? Men who skip screenings face a...